Skip to content
Research Article Open access CC BY 4.0

The Management of Degenerative Complete Heart Block in the Time of Coronavirus

Jaouad Nguadi, Meryem Bennani, Youssef Lahmouz, Zaynab Mouhib, Abdelilah Benelmekkki, Najat Mouine, Hicham Bouzelmat, Ali Chaib, Aatif Benyass

Asian Journal of Cardiology Research · pp. 273–279 · Published 3 Sep 2022

Abstract

The use of chloroquine for SARS COV2 has been adopted by many countries around the world, including Morocco. The Chloroquine is known for its anti-arrhythmic and bradycardic effects and for its formal contraindication in cardiac conduction disorders, long QT and high-degree heart block, which makes the management of a complete heart block in a positive Covid a great dilemma for the rhythmologist. In this article, we describe the management of the association COVID 19-symptomatic high-degree heart block.

Chloroquine COVID-19 complete heart block

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.